RudaCure has completed the expansion of its 首尔 office, which began on July 18th.
The 首尔 office, spanning a total of 145 pyeong (approximately 480 m²), has been relocated with the Clinical Team at its core along with the in vitro analysis team. As a result, the existing headquarters in 松岛 will focus on in vivo 疗效 testing and internal 管线 research, while the 首尔 office will conduct MoA analysis alongside FLIPR services.
With the expansion of the business premises, the company will reorganize its research structure and strengthen its internal capabilities by reinforcing the research team. Through organizational restructuring, the plan is to accelerate both domestic and overseas 临床试验 for RCI001 while simultaneously strengthening new 管线s.
The 首尔 office is located at Ace Hi-End 3rd Building, Suite 1001, Gasan Digital Complex.
